Maa: Yhdistynyt kuningaskunta
Kieli: englanti
Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Doxazosin mesilate
Kent Pharma (UK) Ltd
C02CA04
Doxazosin mesilate
2mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050400
680 Artwork No. Customer Description Market Language Size Min. Font Size Page No. Version No. Date Software 180719/2 Ennogen Doxazosin Leaflet UK English 130 x 480 mm 9 pt 1 of 1 1 18-07-19 Coreldraw 12 Packaging Development Quality Assurance (QA) Quality Control (QC) Production e-mail : prasad.pdp@gmail.com Ph : +91-09845156610 Colours Used Black Keyline Doxazosin 1mg, 2mg, 4mg and 8mg Tablets (doxazosin mesilate) PACKAGE LEAFLET: INFORMATION FOR THE USER ! If you have any further questions, ask your doctor, pharmacist or nurse. 2. What you need to know before you take Doxazosin Tablets It is used to treat: 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DOXAZOSIN TABLETS ! Symptoms caused by the enlargement of the prostate gland in men. 4. Possible side effects If you are undergoing eye surgery because of cataracts (cloudiness of the lens) please inform your eye specialist before the operation that you are using or have previously used Doxazosin Tablets. This is because doxazosin may cause complications during the surgery which can be managed if your specialist is prepared in advance. Before starting treatment with Doxazosin Tablets your doctor may perform tests to rule out other conditions such as prostate cancer that may cause the same symptoms as benign prostatic hyperplasia (enlargement of the prostate gland). Persistent painful erections may occur very rarely. If this happens you should contact a doctor immediately. 6. Contents of the pack and other information ! If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. ! Keep this leaflet. You may need to read it again. ! This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. WHAT IS IN THIS LEAFLET 1. What Doxazosin Tablets are and what they are used for 5. How to store Doxazosin Tablets ! High blood pressure In patients taking this medicine to treat high blood pressure (hyp Lue koko asiakirja
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Doxazosin 2mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.425mg of doxazosin mesilate equivalent to 2mg doxazosin. For excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablets White, oblong tablets, scored and embossed D2 on the same side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _HYPERTENSION: _ Doxazosin is indicated for the treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. In patients inadequately controlled on single antihypertensive therapy, doxazosin may be used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, calcium antagonist or an angiotensin converting enzyme inhibitor. _BENIGN PROSTATIC HYPERPLASIA: _ Doxazosin is indicated for the treatment of urinary outflow obstruction and symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin may also be used in BPH patients who are either hypertensive or normotensive. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Doxazosin may be administered in the morning or in the evening. HYPERTENSION:_ _ Doxazosin is used in a once daily regimen: the initial dose is 1mg to minimize the potential for postural hypotension and/or syncope (see section 4.4 Special Warnings and Precautions for Use). Dosage may be increased after one or two weeks of therapy to 2 mg and thereafter, if necessary, to 4 mg. The majority of patients who respond to doxazosin will do so at a dose of 4mg or less.Dosage can be further increased, if necessary to 8 mg or the maximum recommended dose of 16 mg. BENIGN PROSTATIC HYPERPLASIA: The recommended initial dose of doxazosin is 1mg given once daily to minimise the potential for postural hypotension and/or syncope (see section 4.4 Special Warnings and Precautions for Use). Depending on the individual patients urodynamics and BPH symptomatology dosage may be increased to 2 mg and thereafter to 4 mg and up to the maximum recommended dose of 8 mg Lue koko asiakirja